The Implantable Neurostimulators Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for implantable neurostimulators has seen substantial growth historically. It expanded from $6.06 billion in 2024 and is projected to reach $6.76 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%.
The implantable neurostimulators global market is projected to reach $10.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%.
Download Your Free Sample of the 2025 Implantable Neurostimulators Market Report and Uncover Key Trends Now!The key drivers in the implantable neurostimulators market are:
• Increased prevalence of neurological disorders
• Growth in minimally invasive procedures
• Rising demand for non-opioid pain management
• Expansion of collaborations and partnerships within the industry
The implantable neurostimulators market covered in this report is segmented –
1) By Product Type: Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Other Product Types
2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Uses
Subsegments:
1) By Spinal Cord Stimulators: Conventional Spinal Cord Stimulators, Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, High-Frequency Spinal Cord Stimulators
2) By Deep Brain Stimulators: Single Lead Deep Brain Stimulators, Dual Lead Deep Brain Stimulators, Rechargeable Deep Brain Stimulators, Non-Rechargeable Deep Brain Stimulators
3) By Sacral Nerve Stimulators: Rechargeable Sacral Nerve Stimulators, Non-Rechargeable Sacral Nerve Stimulators, Implantable Pulse Generators for Sacral Nerve Stimulation
4) By Vagus Nerve Stimulators: Rechargeable Vagus Nerve Stimulators, Non-Rechargeable Vagus Nerve Stimulators, Vagus Nerve Stimulation Systems for Epilepsy Treatment
5) By Other Product Types: Transcranial Magnetic Stimulation (TMS) Devices, Peripheral Nerve Stimulators, Cochlear Implants
The key trends in the implantable neurostimulators market are:
• Advancements in technology are shaping the future of the implantable neurostimulators market.
• There is a trend of moving beyond just treating chronic pain, addressing a broader range of neurological disorders.
• The market is witnessing a shift towards miniaturization and personalization powered by Artificial Intelligence.
• The adoption of remote monitoring and digital therapeutics is an emerging trend.
Major players in the implantable neurostimulators market are:
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• LivaNova plc
• Inspire Medical Systems Inc.
• Nevro Corporation
• Axonics Inc.
• Cirtec Medical Systems LLC
• SPR Therapeutics Inc.
• BlueWind Medical Ltd.
• NeuroPace Inc.
• Bioness Inc.
• ReShape Lifesciences Inc.
• Synapse Biomedical Inc.
• Autonomic Technologies Inc.
• Comphya SA
• Mainstay Medical Holdings plc
• Sigenics Inc.
• Nalu Medical Inc.
• Aleva Neurotherapeutics SA
• Nuvectra Corporation
North America was the largest region in the implantable neurostimulators market in 2024